| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 1 | +0.00% | +10.00% | +4.12% | +5.88% | +5.88% | — |
| 14d | 1 | +0.00% | +8.53% | +1.58% | +6.95% | +6.95% | — |
| 30d | 1 | +100.00% | -30.00% | +1.79% | -31.79% | -31.79% | — |
| 60d | 1 | +0.00% | +0.00% | +6.45% | -6.45% | -6.45% | — |
| 90d | 1 | +100.00% | -8.23% | +13.88% | -22.11% | -22.11% | — |
| 180d | 1 | +100.00% | -15.00% | +18.50% | -33.51% | -33.51% | — |
| 1y | 1 | +0.00% | +457.65% | +38.63% | +419.02% | +419.02% | — |
| 2y | 1 | +100.00% | -18.23% | +39.47% | -57.70% | -57.70% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED |
|---|---|---|---|---|---|---|---|
| GTBP GT BIOPHARMA, INC. | SALE CEO | 4,234,320 | $0.00 | $4.2K | 6,500,000 | Jun 2, 2020 | Jun 4, 2020 ↗ |